Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 238-484-2 | CAS number: 14484-64-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1987-11-25 - 1987-12-09
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 987
- Report date:
- 1987
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- EPA OPP 81-1 (Acute Oral Toxicity)
- Version / remarks:
- revised Nov. 1984
- Deviations:
- no
- GLP compliance:
- yes
- Remarks:
- according to US FDA (21 CFR 58) and US EPA (40 CFR 160 and 40 CFR 792)
- Test type:
- fixed dose procedure
- Limit test:
- yes
Test material
- Reference substance name:
- Ferbam
- EC Number:
- 238-484-2
- EC Name:
- Ferbam
- Cas Number:
- 14484-64-1
- Molecular formula:
- C9H18FeN3S6
- IUPAC Name:
- iron(3+) tris(dimethyldithiocarbamate)
- Test material form:
- solid: particulate/powder
- Details on test material:
- Appearance: Black powder
Bulk density: 0.21 g/mL
Solubility: Water: approximately 1 ppm; acetone: 0.81 g/100mL (20 °C); chloroform: 2 g/100mL (20 °C)
Storage: At ambient temperature in the dark in closed container
Stability: At least 14 days at 55 °C; poor in organic solvents
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
Young adult rats of the Wistar strain (8 weeks old at study start, SPF-quality, randomly bred) were supplied by Charles River Wiga GmbH, Sulzfeld, FRG. Upon receipt each animal was identified with an ear tag. At least five days prior to dosing (acclimatization period) the animals were individually housed in polycarbonate cages containing purified sawdust (Woody clean supplied by Broekman Institute, Someren, The Netherlands) as bedding material. The animals had free access to tap-water (via automatic-nozzles) and a standard pelleted laboratory animal diet (RMH-B, Hope Farms, Woerden, The Netherlands). Certificates of analysis for both diet and drinking water are retained in the N0T0X archives.
ENVIRONMENTAL CONDITIONS
The animal room was air-conditioned, with the temperature maintained within the range of 20-22°C and the relative humidity within the range of 55-70% during the study. The artificial light cycle was 12 hours light, 12 hours dark.
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- methylcellulose
- Details on oral exposure:
- Animals were fasted overnight prior to dosing until 3 hours after administration of the test substance. The test substance was suspended in 1% aqueous methyl cellulose (Boom B.V.. Meppel, The Netherlands) and administered once only by gavage using a stainless steel stomach cannula attached to a disposable plastic syringe. The dose level was 5000 mg/kg body weight. Each time the dose volume was 15 ml/kg body weight. The day of dosing was designated as day 0.
- Doses:
- 5000 mg/kg body weight
- No. of animals per sex per dose:
- 5 males
5 females - Control animals:
- no
- Details on study design:
- Observations
- Duration of observation period following administration: 14 days
- Frequency of observations and weighing: on the day of dosing (approximately once every two hours) and once daily thereafter for 14 days
- Necropsy of survivors performed: yes - Statistics:
- not perfomed
Results and discussion
- Preliminary study:
- In order to establish an appropriate dose range three groups of animals, each comprising 1 male and 1 female, were dosed with an oral dose of test substance at 3200, 4200 and 5600 mg/kg body weight. No mortality occurred during the 7-day observation period. Signs of toxicity were body weight loss, lethargy, piloerection, bloody eye encrustation and diarrhoea. Based on the absence of mortality and the low toxicity, observed in the pilot study, the test could be performed as a limit test. One group of animals, comprising 5 males and 5 females, was treated with a single oral dose of test substance at 5000 mg/kg body weight.
Effect levels
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 5 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- One female rat died on day 4 of dosing.
- Clinical signs:
- other: Signs of toxicity were body weight loss for the female rat found dead, lethargy, piloerection, dacryorrhoea, diarrhoea and emaciation.
- Gross pathology:
- Macroscopic examination of animals at termination did not reveal any abnormalities that were considered test substance related, with the exception of a slightly enlarged liver of the female rat which died on day 4.
- Other findings:
- none
Any other information on results incl. tables
Table 1: Daily Incidence of Mortality and Clinical Observations fo Male and Female Rats Combined Following Acute Oral Dosing of test material | |||||||||||||||||||
Dose level (mg/kg) | Signs of reaction | Number showing effects during day of dosing (hours:minutes) or day of observation (day) | Total mortality | ||||||||||||||||
00:15 | 02:15 | 03:35 | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | |||
5000 | No abnomalities | 10 | 0 | 0 | 1 | 3 | 9 | 4 | 3 | 4 | 5 | 8 | 9 | 9 | 9 | 9 | 9 | 9 | |
Lethargy | 0 | 10 | 10 | 0 | 0 | 1 | 5 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Emaciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Piloerection | 0 | 6 | 10 | 1 | 7 | 1 | 0 | 6 | 5 | 3 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Diarrhoea | 0 | 0 | 0 | 9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Dacryorrhoea | 0 | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Deads | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1/10 |
Table 2: Indivudual body weights and dose volumes acute oral toxicity study of test material in the rat | ||||||
Dose Level (mg/kg) | Animal number | Body Weight (g) on: | Body weight Gain (g) Day 0-14 | Dose Volume (mL) | ||
Day 0* | Day 7 | Day 14 | ||||
5000 (Males) |
3306 | 221 | 220 | 304 | 83 | 3.3 |
3308 | 216 | 224 | 291 | 75 | 3.2 | |
3310 | 230 | 221 | 301 | 71 | 3.5 | |
3312 | 225 | 251 | 313 | 88 | 3.4 | |
3314 | 227 | 227 | 303 | 76 | 3.4 | |
Mean | 224 | 229 | 302 | 79 | ||
S.D. | 5.4 | 12.8 | 7.9 | 6.8 | ||
N | 5 | 5 | 5 | 5 | ||
5000 (Females) |
3113 | 169 | 174 | 218 | 49 | 2.5 |
3115 | 170 | 178 | 222 | 52 | 2.6 | |
3117 | 176 | - | - | - | 2.6 | |
3119 | 174 | 170 | 219 | 45 | 2.6 | |
3121 | 185 | 185 | 252 | 67 | 2.8 | |
Mean | 175 | 177 | 228 | 53 | ||
S.D. | 6.4 | 6.4 | 16.3 | 9.6 | ||
N | 5 | 4 | 4 | 4 | ||
* Day of dosing |
Applicant's summary and conclusion
- Interpretation of results:
- other: EU GHS criteria not met
- Conclusions:
- LD50 value for both males and females was noted as exceeding 5000 mg/kg.
- Executive summary:
The acute oral toxicity of the test item was evaluated in this single-dose study in rats according to EPA OPP 81 -1 (Acute oral toxicity) and in compliance with GLP ( US FDA 21 CFR 58 and US EPA 40 CFR 160 and 40 CFR 792).
One group of Wistar rats, comprising 5 males and 5 females, was treated with a single oral dose of the test material at 5000 mg/kg body weight. One female rat died on day 4 of dosing. Signs of toxicity were body weight loss for the female found dead, lethargy, piloerection, dacryorrhoea, diarrhoea and emaciation. These signs were considered reversible since as of day 9 no more abnormalities were observed during the 14-day observation period. All animals showed body weight gain during the study period. Macroscopic examination of animals at termination did not reveal any abnormalities that were considered test substance related, with the exception of a slightly enlarged liver of the female which died on day 4. Since only one animal died, the LD50 value for both males and females was noted as exceeding 5000 mg/kg body weight.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
